Velan Capital Investment Management LP - Q2 2022 holdings

$98.6 Million is the total value of Velan Capital Investment Management LP's 24 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 56.5% .

 Value Shares↓ Weighting
RDUS BuyRADIUS HEALTH INC$18,370,000
+46.4%
1,771,500
+24.6%
18.63%
+60.0%
LNTH SellLANTHEUS HLDGS INC$17,739,000
+0.2%
268,658
-16.0%
17.99%
+9.6%
ADMA BuyADMA BIOLOGICS INC$12,026,000
+12.9%
6,073,598
+4.3%
12.20%
+23.4%
IMCR  IMMUNOCORE HLDGS PLCads$10,946,000
+24.8%
293,3850.0%11.10%
+36.4%
OPTN  OPTINOSE INC$7,320,000
+48.2%
2,000,0000.0%7.42%
+62.0%
 JASPER THERAPEUTICS INC$5,478,000
-46.2%
3,219,0360.0%5.56%
-41.2%
XBI NewSPDR SER TRcall$3,714,00050,000
+100.0%
3.77%
TELA BuyTELA BIO INC$3,493,000
-33.5%
498,238
+10.4%
3.54%
-27.3%
 THE ONCOLOGY INSTITUTE INC$3,036,000
-29.0%
600,0000.0%3.08%
-22.4%
HCSG BuyHEALTHCARE SVCS GROUP INC$3,012,000
+31.9%
173,000
+40.7%
3.06%
+44.1%
BCRX NewBIOCRYST PHARMACEUTICALS INC$2,381,000225,000
+100.0%
2.42%
CFMS BuyCONFORMIS INC$1,824,000
-37.0%
5,156,406
+11.0%
1.85%
-31.2%
CSU  SONIDA SENIOR LIVING INC$1,739,000
-36.6%
82,8320.0%1.76%
-30.7%
QIPT NewQUIPT HOME MEDICAL CORP$1,396,000302,100
+100.0%
1.42%
RZLT BuyREZOLUTE INC$1,292,000
+27.4%
400,000
+33.3%
1.31%
+39.3%
 CARIBOU BIOSCIENCES INC$1,144,000
-40.8%
210,6950.0%1.16%
-35.4%
NewALIMERA SCIENCES INC$1,023,000187,001
+100.0%
1.04%
SellNYXOAH S A$837,000
-73.2%
90,997
-44.2%
0.85%
-70.7%
XENE NewXENON PHARMACEUTICALS INC$608,00020,000
+100.0%
0.62%
RDUS NewRADIUS HEALTH INCcall$519,00050,000
+100.0%
0.53%
SellSCIENCE 37 HOLDINGS INC$441,000
-93.0%
219,510
-81.3%
0.45%
-92.3%
HZNP NewHORIZON THERAPEUTICS PUB L$237,0002,967
+100.0%
0.24%
GFORWS  GRAF ACQUISITION CORP IV*w exp 05/31/202$5,000
-54.5%
20,0000.0%0.01%
-50.0%
 SOMALOGIC INC*w exp 08/31/202$2,000
-50.0%
2,0600.0%0.00%
-50.0%
Exit2SEVENTY BIO INC$0-23,657
-100.0%
-0.38%
VTRS ExitVIATRIS INC$0-100,000
-100.0%
-1.01%
CMRX ExitCHIMERIX INC$0-400,000
-100.0%
-1.70%
ExitSOMALOGIC INC$0-235,300
-100.0%
-1.75%
RAPT ExitRAPT THERAPEUTICS INC$0-110,000
-100.0%
-2.24%
ATRS ExitANTARES PHARMA INC$0-1,346,971
-100.0%
-5.12%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LANTHEUS HLDGS INC8Q3 202318.0%
ADMA BIOLOGICS INC8Q3 202313.7%
JASPER THERAPEUTICS INC8Q3 202317.8%
TELA BIO INC8Q3 20237.6%
REZOLUTE INC8Q3 20231.3%
OPTINOSE INC7Q3 20237.9%
IMMUNOCORE HLDGS PLC6Q1 202313.7%
ALIMERA SCIENCES INC6Q3 202334.0%
QUIPT HOME MEDICAL CORP6Q3 20234.8%
SONIDA SENIOR LIVING INC6Q1 20232.5%

View Velan Capital Investment Management LP's complete holdings history.

Latest filings
TypeFiled
SC 13G2024-03-28
13F-HR2024-02-14
42024-02-09
SC 13D/A2024-02-09
SC 13G/A2024-01-29
13F-HR2023-11-13
42023-10-04
42023-08-17
SC 13D/A2023-08-16
13F-HR2023-08-11

View Velan Capital Investment Management LP's complete filings history.

Export Velan Capital Investment Management LP's holdings